These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6280211)

  • 21. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development?
    Snodin DJ
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):336-55. PubMed ID: 15546688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro immunotoxicology and immunopharmacology: studies on drugs of abuse.
    Pillai RM; Watson RR
    Toxicol Lett; 1990 Oct; 53(3):269-83. PubMed ID: 2237935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of myelotoxicity caused by environmental chemicals.
    Boorman GA; Luster MI; Dean JH; Campbell ML
    Environ Health Perspect; 1982 Feb; 43():129-35. PubMed ID: 6277616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzo[a]pyrene-induced immunotoxicity in Japanese medaka (Oryzias latipes): relationship between lymphoid CYP1A activity and humoral immune suppression.
    Carlson EA; Li Y; Zelikoff JT
    Toxicol Appl Pharmacol; 2004 Nov; 201(1):40-52. PubMed ID: 15519607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of SRBC antibody responses for immunotoxicity testing.
    Ladics GS
    Methods; 2007 Jan; 41(1):9-19. PubMed ID: 17161298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotoxicity evaluation by immune function tests: focus on the T-dependent antibody response (TDAR) [Overview of a Workshop Session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5-9, 2006 San Diego, CA].
    Herzyk DJ; Holsapple M
    J Immunotoxicol; 2007 Apr; 4(2):143-7. PubMed ID: 18958722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical-induced immunomodulation.
    Koller LD
    J Am Vet Med Assoc; 1982 Nov; 181(10):1102-6. PubMed ID: 6816774
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunosuppressive effect of subchronic exposure to a mixture of eight heavy metals, found as groundwater contaminants in different areas of India, through drinking water in male rats.
    Jadhav SH; Sarkar SN; Ram GC; Tripathi HC
    Arch Environ Contam Toxicol; 2007 Oct; 53(3):450-8. PubMed ID: 17657459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.
    Dietert RR
    J Immunotoxicol; 2008 Oct; 5(4):401-12. PubMed ID: 19404874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of benzo[a]pyrene on Friend virus leukemogenesis, CFU-S viability, and induction of humoral immunity.
    Raikow RB; Okunewick JP; Buffo MJ; Jones DL
    Experientia; 1982 Jan; 38(1):126-7. PubMed ID: 6276223
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening of xenobiotics for direct immunotoxicity in an animal study.
    De Jong WH; Van Loveren H
    Methods; 2007 Jan; 41(1):3-8. PubMed ID: 17161297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotoxicant screening and prioritization in the twenty-first century.
    Luebke R
    Toxicol Pathol; 2012; 40(2):294-9. PubMed ID: 22105646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues with introducing new immunotoxicology methods into the safety assessment of pharmaceuticals.
    Dean JH
    Toxicology; 1997 Apr; 119(1):95-101. PubMed ID: 9129200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended histopathology in immunotoxicity testing: interlaboratory validation studies.
    Germolec DR; Nyska A; Kashon M; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
    Toxicol Sci; 2004 Mar; 78(1):107-15. PubMed ID: 14691208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of immunotoxicity: from animal studies to human biomonitoring.
    Van Loveren H; Steerenberg PA; Vos JG
    Toxicol Lett; 1995 May; 77(1-3):73-80. PubMed ID: 7618171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods and approaches for assessing immunotoxicity: an overview.
    Dean JH; Luster MI; Boorman GA
    Environ Health Perspect; 1982 Feb; 43():27-9. PubMed ID: 7060546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and function studies in immunotoxicity testing.
    Vos JG
    Vet Q; 1981 Oct; 3(4):190-5. PubMed ID: 7027532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.